As supervised psychedelic treatments gain traction, insurers are weighing unfamiliar exposures against established risk-management practices to determine which businesses can qualify for coverage.
The executives we feature in our annual Executives to Watch issue, which publishes each November, are largely nominated by their companies. We like that, because we like to have the cooperation of the insurance carriers in writing about their executives.
Discover how evolving workforce pressures are shaping executive concerns and why managing these challenges as enterprise risks is becoming increasingly important.